Company Filing History:
Years Active: 2011
Title: Caridad Anais Gasmuri González: Innovator in Pharmaceutical Composition
Introduction
Caridad Anais Gasmuri González is a notable inventor based in Ciudad de la Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions aimed at combating tumor growth. Her innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Caridad holds a patent for a pharmaceutical composition containing polypeptide fragments of serralysins. This invention is designed to inhibit the growth of tumoral cells from various histological origins and activated endothelial cells. The composition includes polypeptide fragments of serralysins, specifically the C-terminal fragment, which can be combined with prodigiosins to enhance the antitumoral effect. The prodigiosins are present in concentrations ranging from 0.1 to 100 nM. The anti-proliferative action of this composition is mediated through apoptotic mechanisms, and its in vivo administration demonstrates antitumoral, antiangiogenic, and protective effects against malignant tumors. Caridad has 1 patent to her name.
Career Highlights
Caridad Anais Gasmuri González is affiliated with the Centro de Ingeniería Genética y Biotecnología, where she conducts her research and development activities. Her work at this institution has allowed her to explore innovative solutions in the field of genetic engineering and biotechnology.
Collaborations
Throughout her career, Caridad has collaborated with esteemed colleagues, including Maria Del Carmen Abrahantes Pérez and Jesús Reyes González. These collaborations have fostered a productive research environment and have contributed to the advancement of their collective work in biotechnology.
Conclusion
Caridad Anais Gasmuri González is a pioneering inventor whose work in pharmaceutical compositions holds promise for cancer treatment. Her contributions to the field of biotechnology are noteworthy and reflect her commitment to advancing medical science.